Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,069.00
0.00 (0.00%)
Sep 9, 2026, 9:59 AM IDT

TLV:REKA Cash Flow Statement

Millions ILS. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-15.81-18.076.21-6.91-2.046.62
Depreciation & Amortization
29.930.632.5229.9227.4822.86
Other Amortization
0.180.180.14---
Loss (Gain) From Sale of Assets
-0.36-0.16-23.440.05-0-0.05
Loss (Gain) From Sale of Investments
---0.230.04-0.04-1.19
Loss (Gain) on Equity Investments
0.20.1-0.010.22-0.13
Stock-Based Compensation
00.04-0.140.190.40.45
Other Operating Activities
0.752.06-3.530.25.310.21
Change in Accounts Receivable
-26.120.74-8.516.8-14.56-14.4
Change in Inventory
-1.48-8.5314.122.91-2.5913.19
Change in Accounts Payable
30.440.265.98-2.1926.81-3.83
Change in Income Taxes
7.42.63.48-0.09-2.19-1.35
Change in Other Net Operating Assets
2.953.14-0.05-2.770.42-1.47
Operating Cash Flow
28.0412.9526.5428.353921.17
Operating Cash Flow Growth
199.49%-51.21%-6.38%-27.31%84.24%87.62%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-5.01-7.03-8.69-11.49-6.93-13.49
Sale of Property, Plant & Equipment
0.350.43300.060.030.13
Cash Acquisitions
----9.79-6-25.34
Sale (Purchase) of Intangibles
-0.15-0.14-0.01-0.32-0.55-0.51
Investment in Securities
-0.450.150.04-3.65
Other Investing Activities
---6.16---0.35
Investing Cash Flow
-4.81-6.2915.29-21.5-13.45-35.9

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--11.353--
Long-Term Debt Issued
-223381040
Total Debt Issued
102214.35411040
Short-Term Debt Repaid
--4.96---0.01-4.99
Long-Term Debt Repaid
--24.24-66.73-35.74-24.35-37.78
Lease Payments
-7.76-7.55-7.54-6.39-5.4-4.76
Total Debt Repaid
-26.1-29.2-66.73-35.74-24.36-42.78
Net Debt Issued (Repaid)
-16.1-7.2-52.385.26-14.36-2.78
Common Dividends Paid
-----10-
Other Financing Activities
-2.86-2.17-1.76-13.05--
Financing Cash Flow
-18.96-9.37-54.13-7.78-24.36-2.78

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.010.010.030.030.41-0.78
Net Cash Flow
4.28-2.69-12.28-0.91.61-18.29

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
23.035.9217.8516.8632.077.68
Free Cash Flow Growth
1401.43%-66.82%5.86%-47.42%317.44%-
Free Cash Flow Margin
7.58%1.97%5.55%5.24%10.97%2.91%
Free Cash Flow Per Share
2.040.521.561.482.810.67
Levered Free Cash Flow
28.586.5937.2712.2333.25-0.51
Unlevered Free Cash Flow
32.0610.641.4617.4236.783.01
Free Cash Flow After Leases
15.27-1.6210.3110.4726.672.93

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
6.466.257.258.555.695.74
Cash Income Tax Paid
-0.239.40.996.13.77
Change in Working Capital
13.19-1.7915.024.657.9-7.87